{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:43:30Z","timestamp":1790700210987,"version":"4.1.0"},"reference-count":46,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,1,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Cytomegalovirus (CMV) reactivation is a frequent complication after allogeneic hematopoietic cell transplantation (HCT), whose impact on clinical outcome, in particular on leukemic relapse, is controversial. We retrospectively analyzed 687 HCT recipients with acute myeloid leukemia (AML) and ciclosporin-based immunosuppression to better understand the differential impact of CMV on transplant outcomes depending on AML disease stage and in vivo T cell depletion with antithymocyte globulin (ATG). Without ATG, CMV reactivation associated with significantly reduced relapse, yet its effect was more pronounced for advanced disease AML (P = .0002) than for patients in first complete remission (CR1, P = .0169). Depending on the disease stage, ATG exposure abrogated relapse protection following CMV reactivation in advanced stages (P = .796), while it inverted its effect into increased relapse for CR1 patients (P = .0428). CMV reactivation was associated with significantly increased nonrelapse mortality in CR1 patients without ATG (P = .0187) but not in those with advanced disease and ATG. Following CMV reactivation, only patients with advanced disease had significantly higher event-free survival rates as compared with patients without CMV. Overall, our data suggest that both ATG and disease stage modulate the impact of post-HCT CMV reactivation in opposite directions, revealing a level of complexity that warrants future studies regarding the interplay between antivirus and antitumor immunity.<\/jats:p>","DOI":"10.1182\/bloodadvances.2021005509","type":"journal-article","created":{"date-parts":[[2021,10,8]],"date-time":"2021-10-08T00:38:54Z","timestamp":1633653534000},"page":"28-36","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":35,"title":["Impact of CMV reactivation on relapse of acute myeloid leukemia after HCT is dependent on disease stage and ATG"],"prefix":"10.1182","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1347-3360","authenticated-orcid":false,"given":"Amin T.","family":"Turki","sequence":"first","affiliation":[{"name":"Department of Hematology and Stem Cell Transplantation, West-German Cancer Center,"},{"name":"Institute of Experimental Cellular Therapy, West-German Cancer Center,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Tsachakis-M\u00fcck","sequence":"additional","affiliation":[{"name":"Department of Hematology and Stem Cell Transplantation, West-German Cancer Center,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4956-1760","authenticated-orcid":false,"given":"Saskia","family":"Leserer","sequence":"additional","affiliation":[{"name":"Department of Hematology and Stem Cell Transplantation, West-German Cancer Center,"},{"name":"Institute of Experimental Cellular Therapy, West-German Cancer Center,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9668-5013","authenticated-orcid":false,"given":"Pietro","family":"Crivello","sequence":"additional","affiliation":[{"name":"Institute of Experimental Cellular Therapy, West-German Cancer Center,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Liebregts","sequence":"additional","affiliation":[{"name":"Department of Hematology and Stem Cell Transplantation, West-German Cancer Center,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Betke","sequence":"additional","affiliation":[{"name":"Institute of Experimental Cellular Therapy, West-German Cancer Center,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7530-8892","authenticated-orcid":false,"given":"Ferras","family":"Alashkar","sequence":"additional","affiliation":[{"name":"Department of Hematology and Stem Cell Transplantation, West-German Cancer Center,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2530-4329","authenticated-orcid":false,"given":"Nils B.","family":"Leimk\u00fchler","sequence":"additional","affiliation":[{"name":"Department of Hematology and Stem Cell Transplantation, West-German Cancer Center,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3659-3541","authenticated-orcid":false,"given":"Mirko","family":"Trilling","sequence":"additional","affiliation":[{"name":"Institute for Virology, University Hospital Essen, Essen, Germany; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5827-8000","authenticated-orcid":false,"given":"Katharina","family":"Fleischhauer","sequence":"additional","affiliation":[{"name":"Institute of Experimental Cellular Therapy, West-German Cancer Center,"},{"name":"German Cancer Consortium - Deutsches Konsortium f\u00fcr Translationale Krebsforschung (DKTK)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5050-220X","authenticated-orcid":false,"given":"Dietrich W.","family":"Beelen","sequence":"additional","affiliation":[{"name":"Department of Hematology and Stem Cell Transplantation, West-German Cancer Center,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2021,12,30]]},"reference":[{"issue":"9","key":"2021123016210203600_B1","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S1083-8791(03)00287-8","article-title":"Cytomegalovirus in hematopoietic stem cell transplant recipients: current status, known challenges, and future strategies","volume":"9","author":"Boeckh","year":"2003","journal-title":"Biol Blood Marrow Transplant."},{"issue":"2","key":"2021123016210203600_B2","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1399-3062.2011.00706.x","article-title":"A risk score for early cytomegalovirus reactivation after allogeneic stem cell transplantation identifies low-, intermediate-, and high-risk groups: reactivation risk is increased by graft-versus-host disease only in the intermediate-risk group","volume":"14","author":"George","year":"2012","journal-title":"Transpl Infect Dis."},{"issue":"6","key":"2021123016210203600_B3","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/MOH.0000000000000085","article-title":"The role of cytomegalovirus serostatus on outcome of hematopoietic stem cell transplantation","volume":"21","author":"Ljungman","year":"2014","journal-title":"Curr Opin Hematol."},{"issue":"20","key":"2021123016210203600_B4","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1182\/blood-2015-11-679639","article-title":"Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis","volume":"127","author":"Teira","year":"2016","journal-title":"Blood."},{"issue":"19","key":"2021123016210203600_B5","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1182\/blood-2013-05-499830","article-title":"CMV serostatus still has an important prognostic impact in de novo acute leukemia patients after allogeneic stem cell transplantation: a report from the Acute Leukemia Working Party of EBMT","volume":"122","author":"Schmidt-Hieber","year":"2013","journal-title":"Blood."},{"issue":"7","key":"2021123016210203600_B6","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1182\/blood.V95.7.2240","article-title":"Increased transplant-related morbidity and mortality in CMV-seropositive patients despite highly effective prevention of CMV disease after allogeneic T-cell-depleted stem cell transplantation","volume":"95","author":"Broers","year":"2000","journal-title":"Blood."},{"issue":"7","key":"2021123016210203600_B7","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1182\/blood-2013-02-487074","article-title":"CMV reactivation after allogeneic HCT and relapse risk: evidence for early protection in acute myeloid leukemia","volume":"122","author":"Green","year":"2013","journal-title":"Blood."},{"issue":"4","key":"2021123016210203600_B8","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.bbmt.2017.11.038","article-title":"Impact of cytomegalovirus viral load on probability of spontaneous clearance and response to preemptive therapy in allogeneic stem cell transplantation recipients","volume":"24","author":"Camargo","year":"2018","journal-title":"Biol Blood Marrow Transplant."},{"issue":"5","key":"2021123016210203600_B9","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1182\/blood-2010-08-304121","article-title":"Early human cytomegalovirus replication after transplantation is associated with a decreased relapse risk: evidence for a putative virus-versus-leukemia effect in acute myeloid leukemia patients","volume":"118","author":"Elmaagacli","year":"2011","journal-title":"Blood."},{"issue":"1","key":"2021123016210203600_B10","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.bbmt.2013.10.003","article-title":"Protective effect of cytomegalovirus reactivation on relapse after allogeneic hematopoietic cell transplantation in acute myeloid leukemia patients is influenced by conditioning regimen","volume":"20","author":"Manjappa","year":"2014","journal-title":"Biol Blood Marrow Transplant."},{"issue":"10","key":"2021123016210203600_B11","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/bmt.2013.49","article-title":"CMV reactivation is associated with a lower incidence of relapse after allo-SCT for CML","volume":"48","author":"Ito","year":"2013","journal-title":"Bone Marrow Transplant."},{"issue":"11","key":"2021123016210203600_B12","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1038\/s41409-018-0172-y","article-title":"Early human cytomegalovirus reactivation is associated with lower incidence of relapse of myeloproliferative disorders after allogeneic hematopoietic stem cell transplantation","volume":"53","author":"Peric","year":"2018","journal-title":"Bone Marrow Transplant."},{"issue":"6","key":"2021123016210203600_B13","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1182\/bloodadvances.2019000814","article-title":"Heterogeneous impact of cytomegalovirus reactivation on nonrelapse mortality in hematopoietic stem cell transplantation","volume":"4","author":"Kaito","year":"2020","journal-title":"Blood Adv."},{"issue":"6","key":"2021123016210203600_B14","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/s41409-020-01178-6","article-title":"Scoring system for clinically significant CMV infection in seropositive recipients following allogenic hematopoietic cell transplant: an SFGM-TC study","volume":"56","author":"Beauvais","year":"2021","journal-title":"Bone Marrow Transplant."},{"key":"2021123016210203600_B15","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/978-3-030-02278-5_12","volume-title":"The EBMT Handbook: Hematopoietic Stem Cell Transplantation and Cellular Therapies.","author":"Ayuk","year":"2019"},{"issue":"4","key":"2021123016210203600_B16","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/j.1365-2141.1986.tb07551.x","article-title":"Reduced risk of recurrent leukaemia in bone marrow transplant recipients after cytomegalovirus infection","volume":"63","author":"L\u00f6nnqvist","year":"1986","journal-title":"Br J Haematol."},{"issue":"9288","key":"2021123016210203600_B17","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/S0140-6736(01)06275-4","article-title":"Survival after bone marrow transplantation from cytomegalovirus seropositive sibling donors","volume":"358","author":"Nachbaur","year":"2001","journal-title":"Lancet."},{"issue":"11","key":"2021123016210203600_B18","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/j.bbmt.2015.07.019","article-title":"Cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation is associated with a reduced risk of relapse in patients with acute myeloid leukemia who survived to day 100 after transplantation: the Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group","volume":"21","author":"Takenaka","year":"2015","journal-title":"Biol Blood Marrow Transplant."},{"issue":"4","key":"2021123016210203600_B19","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1080\/10428194.2016.1217524","article-title":"Early CMV-replication after allogeneic stem cell transplantation is associated with a reduced relapse risk in lymphoma","volume":"58","author":"Koldehoff","year":"2017","journal-title":"Leuk Lymphoma."},{"issue":"6","key":"2021123016210203600_B20","doi-asserted-by":"crossref","first-page":"E117","DOI":"10.1002\/ajh.23998","article-title":"The use of ATG abrogates the antileukemic effect of cytomegalovirus reactivation in patients with acute myeloid leukemia receiving grafts from unrelated donors","volume":"90","author":"Busca","year":"2015","journal-title":"Am J Hematol."},{"issue":"9309","key":"2021123016210203600_B21","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/S0140-6736(02)07926-6","article-title":"Survival after bone-marrow transplantation","volume":"359","author":"Remberger","year":"2002","journal-title":"Lancet."},{"issue":"4","key":"2021123016210203600_B22","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/s41409-020-01082-z","article-title":"Efficacy of prophylactic letermovir for cytomegalovirus reactivation in hematopoietic cell transplantation: a multicenter real-world data","volume":"56","author":"Mori","year":"2021","journal-title":"Bone Marrow Transplant."},{"issue":"5","key":"2021123016210203600_B23","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/cid\/ciw370","article-title":"Are we there yet? Impact of the first international standard for cytomegalovirus DNA on the harmonization of results reported on plasma samples","volume":"63","author":"Preiksaitis","year":"2016","journal-title":"Clin Infect Dis."},{"issue":"7","key":"2021123016210203600_B24","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1128\/JCM.00067-13","article-title":"Fully automated quantification of cytomegalovirus (CMV) in whole blood with the new sensitive Abbott RealTime CMV assay in the era of the CMV international standard","volume":"51","author":"Schnepf","year":"2013","journal-title":"J Clin Microbiol."},{"issue":"6","key":"2021123016210203600_B25","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/sj.bmt.1702216","article-title":"Reduced risk of persisting cytomegalovirus pp65 antigenemia and cytomegalovirus interstitial pneumonia following allogeneic PBSCT","volume":"25","author":"Trenschel","year":"2000","journal-title":"Bone Marrow Transplant."},{"issue":"3","key":"2021123016210203600_B26","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1214\/aos\/1176350951","article-title":"A class of K-sample tests for comparing the cumulative incidence of a competing risk","volume":"16","author":"Gray","year":"1988","journal-title":"Ann Stat."},{"issue":"446","key":"2021123016210203600_B27","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc."},{"issue":"318","key":"2021123016210203600_B28","first-page":"626","article-title":"Rectangular confidence regions for the means of multivariate normal distributions","volume":"62","author":"Sidak","year":"1967","journal-title":"J Am Stat Assoc."},{"issue":"3","key":"2021123016210203600_B29","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1182\/blood-2016-04-713644","article-title":"Cytomegalovirus replication reduces the relapse incidence in patients with acute myeloid leukemia","volume":"128","author":"Elmaagacli","year":"2016","journal-title":"Blood."},{"issue":"9","key":"2021123016210203600_B30","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.bbmt.2006.05.008","article-title":"Successful immune reconstitution decreases leukemic relapse and improves survival in recipients of unrelated cord blood transplantation","volume":"12","author":"Parkman","year":"2006","journal-title":"Biol Blood Marrow Transplant."},{"issue":"4","key":"2021123016210203600_B31","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/ajh.26094","article-title":"Cytomegalovirus kinetics after hematopoietic cell transplantation reveal peak titers with differential impact on mortality, relapse and immune reconstitution","volume":"96","author":"Leserer","year":"2021","journal-title":"Am J Hematol."},{"issue":"3","key":"2021123016210203600_B32","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/ajt.15642","article-title":"Optimizing anti-T-lymphocyte globulin dosing to improve long-term outcome after unrelated hematopoietic cell transplantation for hematologic malignancies","volume":"20","author":"Turki","year":"2020","journal-title":"Am J Transplant."},{"issue":"3","key":"2021123016210203600_B33","doi-asserted-by":"crossref","first-page":"622","DOI":"10.3324\/haematol.2018.199802","article-title":"T-cell receptor-\u03b1 repertoire of CD8+ T cells following allogeneic stem cell transplantation using next-generation sequencing","volume":"104","author":"Link-Rachner","year":"2019","journal-title":"Haematologica."},{"issue":"9","key":"2021123016210203600_B34","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.bbmt.2020.04.026","article-title":"T cell clonal dynamics determined by high-resolution TCR-\u03b2 sequencing in recipients after allogeneic hematopoietic cell transplantation","volume":"26","author":"Leick","year":"2020","journal-title":"Biol Blood Marrow Transplant."},{"issue":"3","key":"2021123016210203600_B35","doi-asserted-by":"crossref","first-page":"e0213739","DOI":"10.1371\/journal.pone.0213739","article-title":"Cytomegalovirus-specific CD8+ T-cells are associated with a reduced incidence of early relapse after allogeneic stem cell transplantation","volume":"14","author":"Varanasi","year":"2019","journal-title":"PLoS One."},{"issue":"25","key":"2021123016210203600_B36","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1182\/blood-2015-03-631853","article-title":"CMV reactivation drives post-transplant T cell reconstitution and results in defects in the underlying TCR\u03b2 repertoire","volume":"125","author":"Suessmuth","year":"2015","journal-title":"Blood."},{"issue":"5","key":"2021123016210203600_B37","doi-asserted-by":"crossref","first-page":"e86252","DOI":"10.1172\/jci.insight.86252","article-title":"Origin and evolution of the T cell repertoire after posttransplantation cyclophosphamide","volume":"1","author":"Kanakry","year":"2016","journal-title":"JCI Insight."},{"issue":"7","key":"2021123016210203600_B38","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1182\/blood.2020008464","article-title":"Permissive HLA-DPB1 mismatches in HCT depend on immunopeptidome divergence and editing by HLA-DM","volume":"137","author":"Meurer","year":"2021","journal-title":"Blood."},{"issue":"1","key":"2021123016210203600_B39","doi-asserted-by":"crossref","first-page":"22218","DOI":"10.1038\/s41598-020-79363-2","article-title":"T-cell receptor repertoire of cytomegalovirus-specific cytotoxic T-cells after allogeneic stem cell transplantation","volume":"10","author":"Toya","year":"2020","journal-title":"Sci Rep."},{"issue":"3","key":"2021123016210203600_B40","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/cei.12770","article-title":"Abundant cytomegalovirus (CMV) reactive clonotypes in the CD8(+) T cell receptor alpha repertoire following allogeneic transplantation","volume":"184","author":"Link","year":"2016","journal-title":"Clin Exp Immunol."},{"issue":"5","key":"2021123016210203600_B41","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/ng.3822","article-title":"Immunosequencing identifies signatures of cytomegalovirus exposure history and HLA-mediated effects on the T cell repertoire","volume":"49","author":"Emerson","year":"2017","journal-title":"Nat Genet."},{"issue":"4","key":"2021123016210203600_B42","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/cid\/ciu364","article-title":"Donor cytomegalovirus status influences the outcome of allogeneic stem cell transplant: a study by the European group for blood and marrow transplantation","volume":"59","author":"Ljungman","year":"2014","journal-title":"Clin Infect Dis."},{"key":"2021123016210203600_B43","doi-asserted-by":"crossref","DOI":"10.1182\/blood.2020009492","article-title":"CMV exposure drives long-term CD57+ CD4 memory T cell inflation following allogeneic stem cell transplant","author":"Yeh","year":"2021","journal-title":"Blood."},{"issue":"4","key":"2021123016210203600_B44","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1016\/S2352-3026(17)30029-7","article-title":"Association between anti-thymocyte globulin exposure and survival outcomes in adult unrelated haemopoietic cell transplantation: a multicentre, retrospective, pharmacodynamic cohort analysis","volume":"4","author":"Admiraal","year":"2017","journal-title":"Lancet Haematol."},{"issue":"1","key":"2021123016210203600_B45","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.bbmt.2017.08.029","article-title":"Optimizing antithymocyte globulin dosing for unrelated donor allogeneic hematopoietic cell transplantation based on recipient absolute lymphocyte count","volume":"24","author":"Kennedy","year":"2018","journal-title":"Biol Blood Marrow Transplant."},{"issue":"6424","key":"2021123016210203600_B46","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1126\/science.aat0066","article-title":"Strain-specific antibody therapy prevents cytomegalovirus reactivation after transplantation","volume":"363","author":"Martins","year":"2019","journal-title":"Science."}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/6\/1\/28\/1856158\/advancesadv2021005509.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/6\/1\/28\/1856158\/advancesadv2021005509.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,30]],"date-time":"2021-12-30T16:24:11Z","timestamp":1640881451000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/6\/1\/28\/477213\/Impact-of-CMV-reactivation-on-relapse-of-acute"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,30]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1,11]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2021005509","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,30]]}}}